Legal & General Group
GRDN

Legal & General Group’s Guardian Pharmacy Services GRDN Stock Holding History

Legal & General Group’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Sell
11,734
-6,930
-37% -$268K ﹤0.01% 2402
2026
Q1 		$703K Sell
18,664
-2,396
-11% -$78.3K ﹤0.01% 2263
2025
Q4 		$634K Buy
21,060
+3,269
+18% +$92.5K ﹤0.01% 2349
2025
Q3 		$467K Buy
17,791
+2,896
+19% +$69K ﹤0.01% 2467
2025
Q2 		$317K Buy
14,895
+14,104
+1,783% +$318K ﹤0.01% 2553
2025
Q1 		$16.9K Hold
791
– – ﹤0.01% 3004
2024
Q4 		$16K Buy
+791
New +$16.3K ﹤0.01% 3107

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Legal & General Group's GRDN Position: Q2 2026 in Review

Legal & General Group reduced its Guardian Pharmacy Services (GRDN) stake by 37% in Q2 2026, selling an estimated $268K and leaving 11,734 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Legal & General Group first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. The position peaked at $703K in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Legal & General Group held 11,734 shares of Guardian Pharmacy Services worth $491K as of Q2 2026.
  • Legal & General Group sold 6,930 Guardian Pharmacy Services shares in Q2 2026, an estimated $268K.
  • Guardian Pharmacy Services made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2402 holding.
  • Legal & General Group first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • Legal & General Group's Guardian Pharmacy Services position peaked at $703K in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.